Advanced Medical Solutions Grp PLC Capital Markets Day Notification (9849M)
13 May 2015 - 4:00PM
UK Regulatory
TIDMAMS
RNS Number : 9849M
Advanced Medical Solutions Grp PLC
13 May 2015
13 May 2015
Advanced Medical Solutions Group plc
("AMS" or the "Group")
Capital Markets Day Notification
Winsford, UK, 13 May 2015 - Advanced Medical Solutions Group plc
(AIM: AMS.L), the surgical and advanced woundcare specialist
company, today announces that it will host a Capital Markets Day
for financial analysts and institutional investors on 24 June 2015,
from 12:30 - 16:00 GMT, in London.
The event, which will provide an opportunity for participants to
meet some of the Group's senior management team will begin with a
short corporate update on strategy from Chris Meredith, Chief
Executive Officer, followed by a focus on the US market and
LiquiBand(R) , a surgeon discussion on the benefits of LiquiBand(R)
Fix 8(TM), and a session on innovation and market opportunities
across the complete AMS product platform.
No new material information will be disclosed during the
event.
If you would like to attend, please contact
ams@consilium-comms.com or call +44 (0) 20 3709 5700.
The presentation materials will be made available on the Group's
website www.admedsol.com.
- Ends -
For further information, please visit www.admedsol.com or
contact:
Advanced Medical Solutions Group plc
Chris Meredith, Chief Executive Officer
Mary Tavener, Group Finance Director +44 (0) 1606 545508
Consilium Strategic Communications +44 (0) 20 3709 5700
Mary-Jane Elliott / Jonathan Birt / Matthew Neal / Ivar Milligan AMS@consilium-comms.com
About Advanced Medical Solutions Group plc - see
www.admedsol.com
AMS is a world-leading independent developer and manufacturer of
innovative and technologically advanced products for the global
surgical, wound care and wound closure markets, focused on quality
outcomes for patients and value for payors. AMS has a wide range of
products that include silver alginates, alginates, foams, tissue
adhesives, sutures and haemostats, which it markets under its
brands ActivHeal(R) , LiquiBand(R) and RESORBA(R) as well as
supplying under white label.
AMS's products, manufactured out of two sites in the UK, one in
the Netherlands, two in Germany and one in the Czech Republic, are
sold in 65 countries via a network of multinational or regional
partners and distributors, as well as via AMS's own direct sales
forces in the UK, Germany, the Czech Republic and Russia.
Established in 1991, the Group has approximately 470 employees. For
more information please see www.admedsol.com.
This information is provided by RNS
The company news service from the London Stock Exchange
END
MSCPKBDKCBKDOPD
Advanced Medical Solutions (LSE:AMS)
Historical Stock Chart
From Apr 2024 to May 2024
Advanced Medical Solutions (LSE:AMS)
Historical Stock Chart
From May 2023 to May 2024